Trial Profile
Clinical Trials Insight: 700013038
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Aug 2010
Price :
$35
*
At a glance
- Drugs CTCE 9908 (Primary)
- Indications Advanced breast cancer; Lung cancer; Ovarian cancer; Prostate cancer
- Focus Adverse reactions
- Sponsors Chemokine Therapeutics
- 13 Mar 2007 Interim tolerability results have been reported
- 12 May 2006 New trial record.